Tag Archives: Portfolio

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

Why the Bears Are Wrong About The Scotts Miracle-Gro Stock

In mid-June home lawn and fertilizer care specialist The Scotts Miracle-Gro Company (NYSE:SMG) lowered its full-year fiscal 2017 outlook, citing a more than 10% drop in mass retail sales compared to the year-to-date checkpoint from the previous year. That was caused by challenging weather this spring in core markets across the United States.

Public Markets

Planning Ahead for the Changing Times in Cannabis Public Markets

With the exception of the late-2013 to early-2014 bubble, from which fortunes were made, there has been little sustained progress in producing a truly public company sector Version 2.0. No doubt companies like Massroots (OTCQB: MSRT) have set the bar higher.

Viridian Capital Advisors Report TheStreet Index and Northsight Capital and MSN and Conde Nast and Virtual Conference

TheStreet Conducts TV Interview With Viridian Capital Advisors

NEW YORK, June 24, 2015 /Weed Wire/ — TheStreet recently conducted a TV interview with Scott Greiper, President of Viridian Capital Advisors, to discuss the investment opportunity in the cannabis industry and how investors can begin to navigate the complex environment.

GWPH

GWPH Business Plan: Alan Brochstein’s Thoughts

Alan Brochstein has followed quite closely recent developments in the medical and financial world insofar as they have affected GW Pharmaceuticals (NASDAQ: GWPH), the developer of two promising cannabis-based medications.


Top